Marina Grubić

Dr. Marina Grubić

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
NMNikolina Režić Mužinić
Nikolina Režić Mužinić
Maja Veršić BratinčevićMaja Veršić Bratinčević
Maja Veršić Bratinčević
Marina GrubićMarina Grubić
Marina Grubić
RMRoberta Frleta Matas
Roberta Frleta Matas
Martina ČagaljMartina Čagalj
Martina Čagalj
Marijana PopovićMarijana Popović
Marijana Popović
Cantharellus cibarius, the golden chanterelle, is the second most-collected wild edible mushroom in Europe and very frequently harvested in Croatia. Wild mushrooms have been considered a healthy food since ancient times and are today highly valued for their beneficial nutritional as well as medicinal properties. Since golden chanterelle is added to different food products to improve their nutritive value, we studied the chemical profile of aqueous extracts of golden chanterelle (at 25 °C and 70 °C) and their antioxidant and cytotoxic activities. Malic acid, pyrogallol and oleic acid were some of the main compounds identified by GC-MS from derivatized extract. p-Hydroxybenzoic acid, protocatechuic acid and gallic acid were the most abundant phenolics quantitatively determined by HPLC, with somewhat higher amounts for samples extracted at 70 °C. Antioxidant activity was determined by ferric reducing antioxidant power assay and oxygen radical absorption method, and the highest results were recorded for golden chanterelle extracted at 70 °C, being 41.54 ± 1.54 and 38.72 ± 2.47 µM TE/L, respectively. Aqueous extract at 25 °C showed the better response against human breast adenocarcinoma MDA-MB-231 (IC50 = 375µg/mL). Our results confirm the beneficial effect of golden chanterelle even under aqueous extraction conditions and highlight its significance as a dietary supplement and in the development of new beverage products.

4 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJosipa Radić
Josipa Radić
Andrej BelančićAndrej Belančić
Andrej Belančić
HĐHana Đogaš
Hana Đogaš
MVMarijana Vučković
Marijana Vučković
TĐTina Đogaš
Tina Đogaš
Mislav RadićMislav Radić
Mislav Radić
Background and Objectives: Regular physical activity (PA) and Mediterranean diet (MeDi) adherence independently improve glycemic control and clinical outcomes in type 2 diabetes mellitus (T2DM). This study examined the associations between PA, body composition (BC), MeDi adherence, and glycemic control in Dalmatian T2DM patients. Materials and Methods: A cross-sectional study was conducted at the University Hospital of Split (November–December 2023) during an open call for T2DM patients. Data collected included blood/urine samples, blood pressure, BC, and anthropometrics. MeDi adherence and PA were assessed via the Mediterranean Diet Service Score and the International PA Questionnaire-Short Form. Results: Among 252 participants (median age: 67 years, IQR: 60–73; 51.6% women; median T2DM duration: 10 years, IQR: 6–20), PA levels were low (31.4%, N = 79), moderate (45.2%, N = 114), and high (23.4%, N = 59), with uniformly low MeDi adherence across groups. Low PA was associated with higher body mass index (BMI) and lower phase angle (PhA). PA negatively correlated with fat mass (FM; %) and visceral adiposity. Positive BMI predictors included FM (kg), total body water, visceral fat level, and PhA, while fat-free mass, intracellular water, and FM (%) were negative predictors. The estimated glomerular filtration rate was the only positive predictor of the total metabolic equivalent of the task score. Conclusions: PA enhances BC and metabolic health, but inadequate MeDi adherence limits these benefits in the T2DM population. To optimize glucose control and health outcomes, public health initiatives must emphasize MeDi adherence and a combination of aerobic and resistance training.

8 October 2024 in Medicina
Verified
Journal Article
Open access
PDF file
JRJosipa Radić
Josipa Radić
MVMarijana Vučković
Marijana Vučković
HĐHana Đogaš
Hana Đogaš
Marina GrubićMarina Grubić
Marina Grubić
Andrej BelančićAndrej Belančić
Andrej Belančić
Mislav RadićMislav Radić
Mislav Radić
Background and Objectives: Kidney disease (KD) is a common complication of diabetes mellitus (DM) associated with adverse outcomes of renal failure, cardiovascular disease, and mortality. The aim of this study was to determine the prevalence and awareness of the KD among the DM type 2 (T2DM) patients. Materials and Methods: This cross-sectional study was conducted at the University Hospital of Split between November and December of 2023 during an open call for DM patients. For each participant, blood and urine samples, along with relevant medical information, were collected, and adherence to the Mediterranean diet (MeDi) was assessed using the Mediterranean Diet Service Score (MDSS). Furthermore, blood pressure was measured, along with body composition and anthropometric parameters. Results: Of 252 T2DM patients with a median age of 67 years (IQR: 60–73), 130 (51.6%) were women. The median duration of T2DM was 10 years (IQR: 6–20). Despite the fact that 80.95% of total participants reported receiving dietary guidelines from any source, only 53.2% reported adhering to the suggested instructions, while according to the MDSS, only 7.2% adhered to the MeDi. The median body mass index was 27.6 kg/m2 (24.2–31), with 70.1% of participants overweight or obese. Only 6% of participants believed they had KD, but after blood and urine sample analysis, 31% were found to have KD. Conclusions: This study highlights a significant gap in awareness of KD, low adherence to MeDi, and a high prevalence of obesity among T2DM patients. Due to the increasing number of T2DM patients, it is crucial to improve healthy lifestyle education and make modifications within this group, as well as perform regular screening for KD and medical check-ups.

24 May 2022 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
Marina GrubićMarina Grubić
Marina Grubić
MVMiro Vuković
Miro Vuković
JRJosipa Radić
Josipa Radić

2 October 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
JRJosipa Radić
Josipa Radić
MVMarijana Vučković
Marijana Vučković
HĐHana Đogaš
Hana Đogaš
AØAnders Ødeverp
Anders Ødeverp
Marina GrubićMarina Grubić
Marina Grubić
Mislav RadićMislav Radić
Mislav Radić
Background/Objectives: Cardiometabolic risk remains a major challenge in patients with type 2 diabetes mellitus (DMT2). This study aimed to evaluate cardiovascular (CV) risk stratification using advanced glycation end-products (AGEs) measured via skin autofluorescence (SAF) and to assess the achievement of evidence-based ABC targets (HbA1c, blood pressure, low-density lipoprotein (LDL) cholesterol) in adults with DMT2 in Dalmatia. Methods: In this single-center cross-sectional study, 251 adults with DMT2 were stratified by CV risk based on SAF measured AGE levels. Clinical, biochemical, and anthropometric data were collected, including ABC goal attainment and medication use. Statistical analyses compared groups and explored predictors of ABC target achievement using regression models adjusted for clinical factors. Results: Only 17.5% of participants achieved all three ABC goals, indicating suboptimal cardiometabolic control. Those with elevated CV risk had higher hip circumference and lower diastolic blood pressure. Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors was positively associated with ABC goal achievement in patients with prior CV or cerebrovascular events, while higher body mass index was negatively associated. SAF measured AGE levels correlated with cardiometabolic risk but showed no significant differences across LDL cholesterol or other traditional markers. Conclusions: SAF AGE measurement shows potential for CV risk stratification in DMT2 beyond traditional factors. The low rate of ABC goal attainment highlights the need for intensified individualized management incorporating novel biomarkers and therapeutics like SGLT2 inhibitors. Further prospective studies are needed to validate these findings and improve prevention of cardiovascular complications in DMT2.

30 May 2026 in Obesities
Verified
Journal Article
Open access
PDF file
JRJosipa Radić
Josipa Radić
HĐHana Đogaš
Hana Đogaš
MNMarijan Nikolić
Marijan Nikolić
EBEma Boras
Ema Boras
Marina GrubićMarina Grubić
Marina Grubić
Mislav RadićMislav Radić
Mislav Radić
Background: Excess body weight is a major global health problem and an established independent risk factor for chronic kidney disease (CKD). This study aimed to determine the prevalence of overweight and obesity and to evaluate sex-, age-, and time-related trends—including the COVID-19 period—among patients treated at the Outpatient Clinic of the Division of Nephrology, Dialysis and Arterial Hypertension, University Hospital of Split, from 2016 to 2024. Methods: This study included 3033 subjects over 18 years of age, 44.8% men and 55.2% women with a mean age of 60 years. Body composition was assessed using the Tanita MC-780 bioelectrical impedance analyzer and body mass index (BMI, kg/m2) was measured. Results: The study population had median BMI of 28.0 kg/m2, with 33.1% overweight and 37% obese participants, including 6.6% with class III obesity. Men showed greater muscle and bone mass (p < 0.001), whereas women had higher fat mass and obesity prevalence (38.2% vs. 35.6%, p < 0.001). Participants under 65 years had higher absolute fat and muscle mass but similar fat percentage compared to older adults. Overweight and obesity prevalence increased with age, peaking at 75–78% in the 55–74-year group. BMI and fat mass rise significantly during and after the COVID-19 period, while phase angle values declined. Conclusions: Excess body weight is highly prevalent in nephrology patients, particularly in middle-aged adults. The COVID-19 pandemic further worsened body composition indicators, reinforcing the need for preventive strategies.